Press Releases

 
Press Releases
Date Title and Summary View
Jun 19, 2012 Expects Final Imaging Results in the First Quarter 2013 MADISON, WI, June 19, 2012 – Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that the University of Wisconsin Carbone Cancer Center (UW...
PDF
Jun 14, 2012 Announces Dismissal with Prejudice of Putative Federal Securities Class Action Lawsuit MADISON, WI, June 14, 2012 – Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced the closing of a public offering...
PDF
Jun 8, 2012 NOVELOS THERAPEUTICS PRICES $5.4 MILLION PUBLIC OFFERING MADISON, WI, June 8, 2012 – Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced the pricing of a public offering of 5,420,800 units at $1.00 pe...
PDF
May 15, 2012 First Patient Enrolled in Second Cohort, Additional Clinical Results Expected in Q3 2012 Expects to Begin Phase 2 Proof-of-Concept Trials in Q1 2013 MADISON, WI, May 15, 2012 – Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel...
PDF
Apr 24, 2012 Demonstrates Positive Initial Imaging Results; Additional Clinical Results Expected by mid-2012 MADISON, WI, April 24, 2012 – Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that the University o...
PDF
Apr 3, 2012 Broad-Spectrum, Cancer-Targeting Therapeutic and Diagnostic Agents Described MADISON, WI, April 3, 2012 – Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that three scientific posters based on research con...
PDF
Mar 15, 2012 Expects Initial Imaging Results in the Second Quarter of 2012 MADISON, WI, March 15, 2012 – Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that the University of Wisconsin Carbone Cancer Center...
PDF
Mar 1, 2012 Broad-Spectrum, Cancer-Targeting Therapeutic and Diagnostic Agents Described MADISON, WI, March 1, 2012 – Novelos Therapeutics, Inc. (OTCQX: NVLT), a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that three scientific posters based on r...
PDF
Dec 1, 2011 MADISON, WI, December 1, 2011 – Novelos Therapeutics, Inc. (OTCBB: NVLT), a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced the pricing of an underwritten public offering of 9,840,000 units at $0.60 per unit for gross proceeds of $5,904,000. Each unit consists of one share of common stock an...
PDF
Oct 19, 2011 MADISON, WI, October 19, 2011 – Novelos Therapeutics, Inc. (OTCBB: NVLT), a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that on October 17, 2011, Judge Judith Fabricant granted Novelos' motion for judgment on the pleadings in the action brought in the Business Litigation Session of the M...
PDF
Page: FirstPrevious ...
18
NextLast